Evidence map›Paper›PMID 36507089›Full record

ArticleThe Lancet regional health. Western Pacific2022

Prevalence of stroke in China, 2013-2019: A population-based study.

Wen-Jun Tu, Yang Hua, Feng Yan, Hetao Bian, Yi Yang, Min Lou, Dezhi Kang, Li He, Lan Chu, Jingsheng Zeng and 6 more

Abstract read
In one paragraph

Article in The Lancet regional health. Western Pacific, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Wen-Jun TuThe General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China.
Yang HuaDepartment of Ultrasound Vascular, Xuanwu Hospital Capital Medical University, Beijing, China.
Feng YanDepartment of Neurosurgery, Capital Medical University Xuanwu Hospital, Beijing, China.
Hetao BianThe General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China.
Yi YangDepartment of Neurology, the First Bethune Hospital of Jilin University, Changchun, China.
Min LouDepartment of Neurology, the Second Affiliated Hospital of Zhejiang University, Hangzhou, China.
Dezhi KangDepartment of Neurosurgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Li HeDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Lan ChuDepartment of Neurology, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Jingsheng ZengDepartment of Neurology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Jian WuDepartment of Neurology, Beijing Tsinghua Changgung Memoria Hospital, Beijing, China.
Huisheng ChenDepartment of Neurology, The General Hospital of Northern Theater Command of the Chinese People's Liberation Army, Shenyang, China.
Jianfeng HanDepartment of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Lin MaDepartment of Interventional Radiology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Lei CaoThe General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China.
Longde WangThe General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The stroke burden in China has increased during the past 40 years. The present study aimed to determine the recent trends in the prevalence of stroke from 2013 to 2019 stratified by sociodemographic characteristics, including sex, age, residence, ethnicity, and province within a population-based screening project in China. Methods: We made use of data generated from 2013 to 2019 in the China Stroke High-risk Population Screening Program. All living subjects with confirmed stroke at interview were considered to have prevalent stroke. All analyses of prevalence of stroke were weighted and results were presented as percentage and 95% confidence interval (CI). Findings: A total of 4229,616 Chinese adults aged ≥40 years from 227 cities in the 31 provinces were finally included. The enrollment rate ranged from 58.8% (2017) to 67.8% (2013). The weighted prevalence of stroke increased annually from 2013 to 2019, being 2.28% (95% CI: 2.28-2.28%) in 2013, 2.34% (2.34-2.35%) in 2014, 2.43% (2.43-2.43%) in 2015, 2.48% (2.48-2.48%) in 2016, 2.52% (2.52-2.52%) in 2017, 2.55% (2.55-2.55%) in 2018, and 2.58% (2.58-2.58%) in 2019 ( Interpretation: The prevalence of stroke in China and most provinces has continued to increase in the past 7 years (2013-2019). These findings, especially in provinces with high stroke prevalence, can help public health officials to increase province capacity for stroke and related risk factors prevention. Fundings: This study was supported by grants from the National Major Public Health Service Projects.

Indexed as

ChinaPrevalenceSociodemographicStroke

Identifiers

PMID36507089
PMCPMC9727498

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.